Company news
Pharmacielo Ltd. (TSXV:PCLO) news
Pharmacielo Ltd. news releases on 6ix. Latest, Oct 23, 2020: PharmaCielo to Participate in Cantor Fitzgerald Latin America Cannabis Seminar
Press releases — page 3
PharmaCielo to Participate in Cantor Fitzgerald Latin America Cannabis Seminar
October 23, 2020
Horizons ETFs Rebalances Marijuana-Focused Index ETF Suite
October 6, 2020
PharmaCielo Announces Financial Results for the Second Quarter Ended June 30, 2020 and Provides Operational Update
August 31, 2020
PharmaCielo to Hold Conference Call to Review Second Quarter 2020 Financial Results
August 18, 2020
PharmaCielo Increases Cannabis Cultivation Through External Contractor to Meet Market Demand for Medicinal Extracts
August 13, 2020
PharmaCielo Announces Results of AGM
August 7, 2020
PharmaCielo Receives Colombian Government Authorization for 10 Tonnes of High-THC Cultivation and Extract Production for Export
July 8, 2020
PharmaCielo Ltd. Closes $4.6 Million Bought Deal Offering
July 3, 2020
PharmaCielo Ltd. Files Final Prospectus for $4 Million Bought Deal Offering
June 28, 2020
PharmaCielo Ltd. Announces $4,000,000 Bought Deal Public Offering
June 10, 2020
PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2020 and Provides Operational Update
June 1, 2020
PharmaCielo Ltd. Obtains Final Receipt for Short Form Prospectus
May 15, 2020
PharmaCielo Welcomes Dr. Claudia Jiménez to Board of Directors
May 12, 2020
PharmaCielo Adds Experienced Senior Leader to Executive Team
May 4, 2020
PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2019
April 30, 2020
PharmaCielo Provides Details for Fourth Quarter and Year-End 2019 Results Conference Call
April 29, 2020
PharmaCielo Ltd. Announces Closing of Previously Announced $8 Million Private Placement Financing
April 15, 2020
PharmaCielo Ltd. Prices $8 Million Offering; Closing Scheduled for April 14
April 6, 2020
PharmaCielo Ltd. Announces Best Efforts Private Placement Offering
April 1, 2020
PharmaCielo Independent Investigation Concludes Short-seller Report Contains Accusations and Claims based on Faulty Interpretation of Events and Information
March 23, 2020
PharmaCielo Issues Statement Regarding Misleading Short Seller Report
March 3, 2020
XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market
January 27, 2020
PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market
January 27, 2020
PharmaCielo Signs Pan-European Distribution Agreement for CBD Isolate and Broad-Spectrum CBD Oil
January 24, 2020
PharmaCielo Added to XCAN - the Newly Created S&P/TSX Cannabis Index
January 22, 2020
PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations
January 20, 2020
/C O R R E C T I O N from Source -- PharmaCielo Ltd./
January 17, 2020
PharmaCielo Awarded Game-Changer Award by MJDaily
December 14, 2019
PharmaCielo Announces Receipt of CAD$3.9 Million Secured Loan Repayment
December 5, 2019
PharmaCielo Graduates to OTCQX® Best Market and Secures DTC Eligibility
December 2, 2019
PharmaCielo Announces Financial Results for the Three and Nine Months Ended September 30, 2019
November 25, 2019
PharmaCielo Announces RSU Grant
November 7, 2019
PharmaCielo Announces Termination of Scheme Implementation Agreement with Creso Pharma
November 5, 2019
PharmaCielo Trading Halted Pending Update from Creso Pharma
November 4, 2019
PharmaCielo Provides Update on Proposed Acquisition of Creso Pharma
November 1, 2019
PharmaCielo Announces Creso Pharma's Receipt of Australian Court Approval to Convene Meeting of Shareholders
October 2, 2019
PharmaCielo Enters the U.S. with $3 Million Q4 Sales Agreement and Completes Introductory Shipments to Multi-state Distributor General Extract LLC
September 25, 2019
PharmaCielo Announces Financial Results for the Second Quarter 2019
August 27, 2019
PharmaCielo's Very First Commercial CBD Export from Colombia Lands in Europe
August 19, 2019
PharmaCielo Expands Further Into Latin America With Sales Agreement to Supply CBD Extracts, Oils and Veterinary Products to Laboratorios Adler
August 13, 2019
PharmaCielo Joins Canadian Market Cannabis Tracking and Verification Initiative
August 8, 2019
PharmaCielo Colombia Holdings S.A.S. Appoints New and Diversified Board of Directors
August 2, 2019
PharmaCielo Achieves Twelvefold Increase in Dried Cannabis Processing Capacity to Meet Global Demand for Medicinal Oil Extracts
August 1, 2019
PharmaCielo Completes Acquisition of Ubiquo Telemedicina
July 26, 2019
PharmaCielo First to Receive Colombian Government Export Approval for Commercial Sale of CBD Isolate
July 25, 2019
PharmaCielo Colombia Holdings S.A.S. Appoints Andres Felipe Botero as Chief Operations Officer
July 22, 2019
PharmaCielo Announces Trading on the OTC Market
June 21, 2019
PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million
June 6, 2019
PharmaCielo Gears Up for U.S. Market Demand, Enlists Former Congressman and Medical Cannabis Advocate Dana Rohrabacher as a Special Advisor
May 29, 2019
PharmaCielo Announces its Financial Results for the First Quarter 2019
May 27, 2019